Literature DB >> 20562664

"En-glove" lysis of lower eyelid retractors with AlloDerm and dermis-fat grafts in lower eyelid retraction surgery.

Heather S Chang1, Diana Lee, Mehryar Taban, Raymond S Douglas, Robert A Goldberg.   

Abstract

PURPOSE: To describe a minimally invasive surgical technique using AlloDerm or dermis-fat grafts for lower eyelid retraction.
METHODS: A retrospective review of all patients undergoing lower eyelid retraction surgery via a minimal invasive, "en-glove" technique from 2005 through 2009. Charts were reviewed for the type of graft (AlloDerm or dermis-fat) used, the etiology of lower eyelid retraction, and the follow-up time. Outcome measures included lower eyelid height (measured from the corneal light reflex to the lower eyelid margin, or MRD2), reduction of lagophthalmos, cosmetic appearance, complications, and need for further surgery. Presurgery and postreconstruction photographs were reviewed and graded for functional and cosmetic outcome.
RESULTS: A total of 8 patients underwent successful lower eyelid retraction surgery using this minimally invasive technique. Etiologies included thyroid eye disease and cicatricial paralytic lower eyelid retraction. Mean improvement in MRD2 was 1.5 mm for the AlloDerm group (4 patients, 7 eyelids) and 1.0 mm for the dermis-fat group (4 patients, 4 eyelids) after a minimum of 3 months' follow-up. The cosmetic result was satisfactory in all cases.
CONCLUSIONS: "En-glove" lower eyelid retraction surgical technique offers a minimally invasive approach for the release of the lower eyelid retractors and allows for volume augmentation using either AlloDerm or dermis-fat spacer graft.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20562664     DOI: 10.1097/IOP.0b013e3181c53d38

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  9 in total

Review 1.  Alloplastic adjuncts in breast reconstruction.

Authors:  Miguel S Cabalag; Marie Rostek; George S Miller; Michael P Chae; Tam Quinn; Warren M Rozen; David J Hunter-Smith
Journal:  Gland Surg       Date:  2016-04

2.  Orbital Adherence Syndrome following the Use of Titanium Precontoured Orbital Mesh for the Reconstruction of Posttraumatic Orbital Floor Defects.

Authors:  Geraldine Hwee Ping Lee; Samuel Yew Ming Ho
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2016-06-23

3.  Improvement of Ocular Surface Disease by Lateral Tarsoconjunctival Flap in Thyroid-Associated Orbitopathy Patients with Lid Retraction.

Authors:  Chih-Kang Hsu; Meng-Wei Hsieh; Hsu-Chieh Chang; Yi-Hao Chen; Ke-Hung Chien
Journal:  J Pers Med       Date:  2022-05-16

4.  Acellular Dermal Matrix in Reconstructive Breast Surgery: Survey of Current Practice among Plastic Surgeons.

Authors:  Ahmed M S Ibrahim; Pieter G L Koolen; Azra A Ashraf; Kuylhee Kim; Marc A M Mureau; Bernard T Lee; Samuel J Lin
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-05-07

5.  Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy.

Authors:  Seung Woo Choi; Jae Yeun Lee; Helen Lew
Journal:  Korean J Ophthalmol       Date:  2016-01-21

6.  Lower Eyelid Retraction Repair with Resorbable Polydioxanone Implants.

Authors:  Adel H Alsuhaibani; Yasser H Al-Faky
Journal:  Middle East Afr J Ophthalmol       Date:  2016 Oct-Dec

7.  Efficacy, safety and complications of autologous fat grafting to the eyelids and periorbital area: A systematic review and meta-analysis.

Authors:  Fan Yang; Zhaohua Ji; Liwei Peng; Ting Fu; Kun Liu; Wenjie Dou; Jing Li; Yuejun Li; Yong Long; Weilu Zhang
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

Review 8.  Management of eyelid retraction related to thyroid eye disease.

Authors:  Tammy H Osaki; Lucas G Monteiro; Midori H Osaki
Journal:  Taiwan J Ophthalmol       Date:  2022-02-14

Review 9.  Reanimating the paralyzed face.

Authors:  Kofi Boahene
Journal:  F1000Prime Rep       Date:  2013-11-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.